| Date Filed | Type | Description |
| 08/15/2023 |
4
| MILLS ROBERT S (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 40,000 shares
@ $0.25, valued at
$10k
|
|
| 12/30/2022 |
4
| MILLS ROBERT S (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Granted 33,475 options to buy
@ $0.85, valued at
$28.5k
|
|
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| MILLS ROBERT S (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 22,794 shares
@ $14.58, valued at
$332.3k
Exercised 22,794 options to buy
@ $2.5, valued at
$57k
|
|
| 08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| MILLS ROBERT S (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Granted 2,351 options to buy
@ $5, valued at
$11.8k
|
|
| 10/29/2019 |
4
| MILLS ROBERT S (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $5, valued at
$25k
Converted 10,980 shares
@ $0
Converted 10,980 preferred shares
@ $0 |
|
| 10/24/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/12/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2010 |
4
| MILLS ROBERT S (President & COO) has filed a Form 4 on COLUMBIA LABORATORIES INC|
Txns:
| Paid exercise price by delivering 2,000 shares
@ $1.3, valued at
$2.6k
|
|
| 05/18/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 03/12/2009 |
4
| MILLS ROBERT S (President & CEO) has filed a Form 4 on COLUMBIA LABORATORIES INC |
| 03/04/2009 |
4
| MILLS ROBERT S (President & CEO) has filed a Form 4 on COLUMBIA LABORATORIES INC |